Cargando…
Inhaled Biologicals for the Treatment of Cystic Fibrosis
BACKGROUND: Cystic Fibrosis (CF), one of the most frequent genetic diseases, is characterized by the production of viscous mucus in several organs. In the lungs, mucus clogs the airways and traps bacteria, leading to recurrent/resistant infections and lung damage. For cystic fibrosis patients, respi...
Autores principales: | Sala, Valentina, Murabito, Alessandra, Ghigo, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751348/ https://www.ncbi.nlm.nih.gov/pubmed/30318010 http://dx.doi.org/10.2174/1872213X12666181012101444 |
Ejemplares similares
-
Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches
por: Ghigo, Alessandra, et al.
Publicado: (2021) -
Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
por: Murabito, Alessandra, et al.
Publicado: (2020) -
It Takes Two to Tango! Protein–Protein Interactions behind cAMP-Mediated CFTR Regulation
por: Murabito, Alessandra, et al.
Publicado: (2023) -
Aztreonam Lysine Inhalation Solution in Cystic Fibrosis
por: Elson, Elizabeth Claire, et al.
Publicado: (2019) -
Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)